TherapeuticsMD Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	7.12	5.06	4.33	38.07	64.91	80.49
Cash & Short-Term Investments	7.12	5.06	4.33	38.07	64.91	80.49
Cash Growth	40.98%	16.92%	-88.63%	-41.35%	-19.36%	-49.96%
Receivables	3.67	3.56	3.09	-	-	32.38
Inventory	-	-	-	-	-	7.99
Prepaid Expenses	0.18	0.07	0.25	1.17	2.73	2.57
Restricted Cash	-	-	-	11.25	-	-
Other Current Assets	3.55	3.57	4.13	4.87	51.83	4.98
Total Current Assets	14.5	12.26	11.8	55.35	119.47	128.4
Property, Plant & Equipment	5.52	6.1	6.87	7.66	9.06	11.51
Other Intangible Assets	3.91	4.32	6.1	6.94	7.14	41.45
Long-Term Accounts Receivable	14.27	16.01	18.48	20.25	-	-
Other Long-Term Assets	0.47	0.13	0.06	0.25	33.8	0.25
Total Assets	38.67	38.82	43.31	90.46	169.47	181.61
Accounts Payable	0.26	0.26	0.03	2.16	3.37	21.07
Accrued Expenses	0.94	0.49	1.66	12.76	9.12	28.86
Current Portion of Long-Term Debt	-	-	-	-	188.27	-
Current Portion of Leases	1.07	1.63	1.47	1.39	1.36	2.25
Other Current Liabilities	2.67	2.78	3.69	30.53	50.77	7.06
Total Current Liabilities	4.95	5.17	6.85	46.84	252.89	59.24
Long-Term Debt	-	-	-	-	-	237.7
Long-Term Leases	5.41	5.54	6.53	7.37	8.06	8.68
Other Long-Term Liabilities	0.87	0.74	0.64	1.11	2.14	-
Total Liabilities	11.23	11.45	14.02	55.32	263.09	305.61
Common Stock	0.01	0.01	0.01	0.01	0.01	0.3
Additional Paid-In Capital	979.21	979.18	978.92	974.5	957.73	754.64
Retained Earnings	-951.77	-951.82	-949.64	-939.36	-1,051	-878.95
Shareholders' Equity	27.44	27.37	29.29	35.14	-93.62	-124
Total Liabilities & Equity	38.67	38.82	43.31	90.46	169.47	181.61
Total Debt	6.48	7.18	8.01	8.76	197.69	248.63
Net Cash (Debt)	0.63	-2.12	-3.68	29.31	-132.79	-168.14
Net Cash Per Share	0.05	-0.18	-0.35	3.13	-16.68	-30.50
Filing Date Shares Outstanding	11.57	11.57	11.53	9.95	8.67	7.76
Total Common Shares Outstanding	11.57	11.53	11.53	9.5	8.6	6
Working Capital	9.56	7.09	4.94	8.51	-133.42	69.17
Book Value Per Share	2.37	2.37	2.54	3.70	-10.89	-20.68
Tangible Book Value	23.53	23.05	23.19	28.2	-100.77	-165.45
Tangible Book Value Per Share	2.03	2.00	2.01	2.97	-11.72	-27.60
Machinery	-	-	-	2.1	2.34	3.19
Leasehold Improvements	-	-	-	0.05	0.08	0.08

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q